Nordson (NDSN) PT Raised to $287 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Nordson Corporation Reports Third Quarter Fiscal 2024 Results and Updates Annual Guidance
August 21, 2024 4:30 PM EDTThird Quarter Highlights:
Sales were $662 million, an increase of 2% year-over-year and in-line with mid-point of guidance Earnings per diluted share were $2.04 Adjusted earnings per diluted share were $2.41, $0.08 above the mid-point of guidanceUpdated Full-Year Guidance:
Increasing full fiscal year 2024 revenue guidance to reflect the addition of Atrion acquisition Maintaining full fiscal year 2024 adjusted earnings per diluted share guidance, inclusive of the slightly dilutive fourth quarter Atrion acquisition impactWESTLAKE,... More
Nordson Corporation Completes Acquisition of Atrion Corporation
August 21, 2024 8:35 AM EDTWESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq: NDSN) (the Company or Nordson) has completed the acquisition of Atrion Corporation (Atrion), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions. The completion of the transaction follows the Companys May 28, 2024 announcement that it had entered into an agreement to acquire the business. This acquisition will expand Nordsons medical... More
